Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT01068405

Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo

Conditions: Polyarthritis

Sex: All
Ages: 40 Years – 85 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 64
Sponsor: Centre Hospitalier Universitaire de Nice

Location: Nice University Hospital, Rheumatology Department Nice

Summary

Interest of methotrexate in inflammatory rheumatisms was demonstrated since several years. At present time,there is no effective treatment against digital arthritis. The investigators purpose to measure the efficacy of methotrexate on digital arthritis. In this aim, two groups were compared. The first group receive 10mg/week of methotrexate administered in one shot (every Monday for example)during 12 months. The second group receive 10mg/week of placebo according to the same procedure

Eligibility Criteria

Inclusion Criteria: * hand arthritis * pain over 40/100 * stable treatment since 4 weeks at least with non-steroid analgesic * between 45 et 85 years Exclusion Criteria: * pregnancy or breast feeding women * hyaluronic acid injection within the past 6 months * cortisonic derivated injection within the past 3 months

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT01068405). StuddyBuddy aggregates publicly available trial information.